LSDs Options
(2018) A blood‐Mind‐barrier‐penetrating anti‐human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II. Mol Ther(2017) A novel approach to assess lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency. Sci RepThe site is protected. The https:// ensures that you'r